Athenex Investor Relations Material
Latest events
Q3 2022
Athenex
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Athenex Inc
Access all reports
Athenex, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel cancer therapies. The company operates through two primary segments: the Oncology Innovation Platform and the Commercial Platform. Its research and development efforts are centered around proprietary cell therapy technologies, including its Natural Killer T-cell (NKT) therapy, aimed at treating cancer. Athenex also manages a commercial division that markets specialty pharmaceutical products, particularly in oncology and related fields. The company is headquartered in Buffalo, New York, and its shares are listed on the OTC market.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
ATNX
Country
🇺🇸 United States